{"version":"1.0","type":"link","title":"Comparing the efficacy and safety of the ABC-14 regimen (azacitidine, venetoclax, and chidamide) with traditional \"3 + 7\" intensive induction regimen or AB-14 regimen (venetoclax combined with azacitidine) in newly diagnosed AML: study protocol for a prospective, multicenter, randomized, open-label clinical trial.","author_name":"Yan H 외","author_url":"https://prs-insight.online/author/Yan%20H","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/164786","thumbnail_width":1200,"thumbnail_height":630}